EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Efficacy and Safety of Direct Oral Anticoagulants Versus Standard Anticoagulation for Thromboprophylaxis in Nephrotic Syndrome: A Systematic Review and Meta-Analysis

Lihua Shi iD, Mengjin Jiang, Xiaoying Zhang, Congyao Wang, Wenze Yu

Clinical and Applied Thrombosis/Hemostasis · 2026-01 · 32

DOI: 10.1177/10760296261442053 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 08.04.2026. Verfasst von Lihua Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Anticoagulants, Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Major Science and Technology Plan Project of Xiaoshan District, Zhejiang Provincial Medical and Health Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prophylactic anticoagulation (PAC) is used to reduce the risk of thrombosis in patients with nephrotic syndrome (NS), yet the optimal agent remains uncertain. This systematic review and meta-analysis compare the efficacy and safety of direct oral anticoagulants (DOACs) versus standard-of-care (SOC; heparins or cumarins) for thromboprophylaxis in NS. We systematically searched PubMed, Cochrane Library, Web of Science, and MEDLINE from inception to June 2025. Five cohort studies involving 399 adult patients were included. Pooled analysis indicated that while DOACs were associated with a higher risk of thrombotic events, they demonstrated a superior safety profile by significantly reducing the overall risk of bleeding events. The risk of major bleeding was comparable between the two strategies. These findings underscore the paramount importance of individualized risk-benefit assessment in clinical practice. The current evidence, derived from observational studies, calls for further validation from randomized controlled trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrotic SyndromeAnticoagulantsThrombosisHumansAdministration, OralHemorrhage

Stichwörter der Autor:innen

anticoagulationdirect oral anticoagulantshemorrhagemeta-analysisnephrotic syndromethrombosis

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Pharmacy, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, China.

ORCID-Profile: Lihua Shi

Förderung

  • the Major Science and Technology Plan Project of Xiaoshan District
  • Zhejiang Provincial Medical and Health Science and Technology Plan

Zitieren

APA

Shi, L., Jiang, M., Zhang, X., Wang, C., & Yu, W. (2026). Efficacy and Safety of Direct Oral Anticoagulants Versus Standard Anticoagulation for Thromboprophylaxis in Nephrotic Syndrome: A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis, 32. https://doi.org/10.1177/10760296261442053

Vancouver

Shi L, Jiang M, Zhang X, Wang C, Yu W. Efficacy and Safety of Direct Oral Anticoagulants Versus Standard Anticoagulation for Thromboprophylaxis in Nephrotic Syndrome: A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis. 2026;32. doi:10.1177/10760296261442053

BibTeX
@article{Shi2026,
  author = {Shi, Lihua and Jiang, Mengjin and Zhang, Xiaoying and Wang, Congyao and Yu, Wenze},
  title = {Efficacy and Safety of Direct Oral Anticoagulants Versus Standard Anticoagulation for Thromboprophylaxis in Nephrotic Syndrome: A Systematic Review and Meta-Analysis},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2026},
  volume = {32},
  doi = {10.1177/10760296261442053}
}
Kostenlos starten →